PBS
How The Prescription Drug Supply Chain Is Killing Local Pharmacies
The supply chain that brings pharmaceutical drugs from the factory to the pharmacy is long, complex and unclear. Congress and several state legislatures have proposed or enacted laws to bring more transparency and curb soaring drug...
The Wall Street Journal
The Power of the Employer
As major purchasers of health care for their workers, employers carry a large burden of health care costs. How are big companies wielding their influence to lower costs and improve quality?
The Business Professor
Sales Promotion: Strategies and Tools for Marketing Success
This video discusses the concept of sales promotion as a targeted marketing strategy. The speaker highlights tools like coupons, discounts, rebates, allowances, samples, and point of purchase displays as effective means of sales promotion.
Mediacorp
Exploring Green Car Options
This video explores the options and costs associated with green cars, specifically hybrid and electric vehicles. It highlights the benefits of electric cars, such as zero emissions and smooth driving experience, but also acknowledges...
The Wall Street Journal
An Alternative Stock Market
What does fairness mean when it comes to markets and trading? Hear from a founder taking on the NYSE and Nasdaq about the future of stock trades and the financial markets.
Bloomberg
Sen. Grassley on Drug Pricing, Debt Ceiling, Presidential Power
Feb.26 -- Senator Chuck Grassley, chairman of the Senate Finance Committee and a Republican from Iowa, discusses bills aimed at reducing prescription drug prices ahead of a hearing with pharmaceutical executives, raising the debt...
Bloomberg
IEX CEO Says SEC Pilot Program Will Show Rebates Underpin Market Conditions
Jul.09 -- The Securities and Exchange Commission unanimously voted back in March on a pilot program that would examine how transaction fees and rebates that stock exchanges use to attract trades impact the market and if they present...
Bloomberg
AstraZeneca Supports Trump's Drug-Rebate Overhaul, CEO Says
Feb.14 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot discusses the Trump administration's plan to lower U.S. drug costs by banning some payments to middlemen. He spoke after the Cambridge, England-based company forecast...
Bloomberg
AstraZeneca CEO on Impact of Midterms on Drug Market
Nov.08 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot discusses the impact of the midterm elections on the U.S. drug market. He also comments on global pricing and China in an interview with Bloomberg Television's Guy Johnson.
Curated Video
Inflation Reduction Act: How It Could Impact Your Wallet
The Congressional Budget Office says the bill is likely to reduce the deficit by up to $102 billion over 10 years.
Bloomberg
VW of America CEO Keogh on New EV Crossover
Sep.23 -- Volkswagen Group of America President and Chief Executive Officer Scott Keogh discusses the automaker's new ID.4 crossover on "Bloomberg Markets."
Bloomberg
Dutch PM Rutte on EU Recovery Plan, Governance
Jul.17 -- European Union leaders are meeting in Brussels today to discuss a radical 750 billion-euro fund designed to help the bloc’s economies recover from the worst recession in living memory. Leaders are still deeply divided over key...
Bloomberg
Deloitte: FC Barcelona Retains Top Money League Spot
Jan.26 -- Dan Jones, lead partner of the Sports Business Group at Deloitte, discusses the key findings from the firm's annual Football Money League Report. He speaks with Bloomberg's Laura Wright.
Curated Video
The Associated Press tracked talks to a small but broadly diverse group of consumers who tracked their rebate spending in detail. The analysis shows there was no mass rush to the malls for shopping sprees after the payments started showing up in bank accounts in significant numbers in May.
HEADLINE: How are tax payers spending their rebates?
CAPTION: Chicagoan Vanessa Church already spent her tax rebate. The Associated Press analysis of the spending of a small diverse group of consumers shows there was no mass rush to...
Bloomberg
Sen. Braun Say Trump Budget 'Unrealistic' on Growth
Mar.13 -- Senator Mike Braun, an Indiana Republican, discusses his proposed bills aimed at lowering drug costs, President Donald Trump's fiscal 2020 budget proposal, and the funding of the Federal Aviation Administration. He speaks with...
Bloomberg
IEX CEO Says Listings Business Was More Challenging Than Expected
Sep.23 -- Brad Katsuyama, IEX Group Inc. co-founder and chief executive officer, discusses IEX's decision to exit the corporate listings business. He speaks with Bloomberg's Erik Schatzker on "Bloomberg Markets: The Close."
Curated Video
President Bush has signed a $168 billion economic stimulus plan, calling it 'a booster shot for our economy.'
HEADLINE: Bush signs economic stimulus package
CAPTION: President Bush has signed a $168 billion economic stimulus plan, calling it 'a booster shot for our economy.' Democrats and Republicans who put aside deep differences to craft the...
Bloomberg
U.K. Deems EU Tax Bill ÷Unacceptable
Nov. 7 -- Bloomberg's Rob Hutton reports on the EU tax bill on Britain and how Camerons coming election is impacting the outcome. He speaks with Francine Lacqua on Bloomberg Televisions The Pulse. (Source: Bloomberg)
Bloomberg
Citron's Left Calls Express Scripts Drug Price Culprit
Dec.09 -- Andrew Left, founder at Citron Research, explains his call that Express Scripts Holding Co. is "the culprit behind pharmaceutical price gouging" and why he is singling out the company from the rest of the industry. He speaks on...
Bloomberg
The Hidden Cost of Cheaper Drug Prices
May 5 -- Despite political uproar over U.S. drug pricing, pharmacy benefit managers, or PBMs, such as CVS Caremark and Express Scripts are the only ones that have really managed to lower drug prices for many. But their controversial...
Bloomberg
What IEX Brings to Markets as a Stock Exchange
June 20 -- Joe Saluzzi, partner at Themis Trading, discusses the decision by the Securities and Exchange Commission to approve IEX Group as a U.S. stock exchange. He speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."